MTM1基因变异致5例新生儿中央核肌病的临床及遗传学分析

谢添, 葛佳静, 张子明, 吴鼎文, 许燕萍, 施丽萍, 马晓路, 陈正

中国当代儿科杂志 ›› 2025, Vol. 27 ›› Issue (9) : 1071-1075.

PDF(561 KB)
HTML
PDF(561 KB)
HTML
中国当代儿科杂志 ›› 2025, Vol. 27 ›› Issue (9) : 1071-1075. DOI: 10.7499/j.issn.1008-8830.2501068
论著·临床研究

MTM1基因变异致5例新生儿中央核肌病的临床及遗传学分析

作者信息 +

Clinical and genetic features of 5 neonates with centronuclear myopathy caused by MTM1 gene variation

Author information +
文章历史 +

摘要

目的 总结分析新生儿中央核肌病的临床表现及基因突变特点。 方法 回顾性分析2020年1月—2024年8月在浙江大学医学院附属儿童医院新生儿重症监护室住院并明确诊断的5例中央核肌病新生儿的临床资料。包括性别、胎龄、出生体重、Apgar评分、临床表现、肌酸激酶、肌电图、基因检测结果及患儿结局等。 结果 5例男性患儿均存在生后窒息复苏史,临床表现为肌张力减退、肌无力、呼吸衰竭,其中2例患儿存在吞咽功能障碍。肌酸激酶检测3例正常,2例轻度升高。3例患儿进行了肌电图检查,其中2例提示肌源性损害。5例患儿均通过基因检测明确为MTM1基因突变,包括2例无义突变、3例错义突变,其中1例变异位点既往未见报道。4例突变遗传自母亲,1例为新发突变。5例患儿治疗后病情无改善,撤机失败,最终放弃治疗后死亡。 结论 MTM1基因突变所致的中央核肌病临床表型严重,预后不良。出生后存在肌张力减退、肌无力的患儿应考虑该疾病,并尽早完善基因检测以明确诊断。

Abstract

Objective To study clinical manifestations and gene mutation features of neonates with centronuclear myopathy. Methods A retrospective analysis was conducted on the medical data of 5 neonates with centronuclear myopathy diagnosed in the Neonatal Intensive Care Unit of Children's Hospital, Zhejiang University School of Medicine from January 2020 to August 2024. The data included gender, gestational age, birth weight, Apgar score, clinical manifestations, creatine kinase level, electromyography, genetic testing results and the outcomes of the infants. Results All 5 male neonates had a history of postpartum asphyxia and resuscitation. They all presented with hypotonia, myasthenia, and respiratory failure; two neonates also had swallowing dysfunction. Of the five neonates, three had normal creatine kinase levels, while two had slightly elevated levels. Electromyography was performed for three neonates, among whom two had myogenic damage. MTM1 gene mutations were identified by genetic testing in all five neonates, including two nonsense mutations and three missense mutations, among which one variant had not been previously reported. Four mutations were inherited from the mother, and the other one was a de novo mutation. The five neonates showed no clinical improvement following treatment, failed weaning from mechanical ventilation, and ultimately died after withdrawal of life-sustaining therapy. Conclusions Centronuclear myopathy caused by MTM1 gene mutation often has a severe phenotype and a poor prognosis, and it should be considered for neonates with hypotonia and myasthenia after birth. Genetic testing should be performed as soon as possible.

关键词

中央核肌病 / MTM1基因 / 新生儿

Key words

Centronuclear myopathy / MTM1 gene / Neonate

引用本文

导出引用
谢添, 葛佳静, 张子明, . MTM1基因变异致5例新生儿中央核肌病的临床及遗传学分析[J]. 中国当代儿科杂志. 2025, 27(9): 1071-1075 https://doi.org/10.7499/j.issn.1008-8830.2501068
Tian XIE, Jia-Jing GE, Zi-Ming ZHANG, et al. Clinical and genetic features of 5 neonates with centronuclear myopathy caused by MTM1 gene variation[J]. Chinese Journal of Contemporary Pediatrics. 2025, 27(9): 1071-1075 https://doi.org/10.7499/j.issn.1008-8830.2501068

参考文献

[1]
Spiro AJ, Shy GM, Gonatas NK. Myotubular myopathy. Persistence of fetal muscle in an adolescent boy[J]. Arch Neurol, 1966, 14(1): 1-14. DOI: 10.1001/archneur.1966.00470070005001 .
[2]
Reumers SFI, Erasmus CE, Bouman K, et al. Clinical, genetic, and histological features of centronuclear myopathy in the Netherlands[J]. Clin Genet, 2021, 100(6): 692-702. PMCID: PMC9292987. DOI: 10.1111/cge.14054 .
[3]
Lawlor MW, Dowling JJ. X-linked myotubular myopathy[J]. Neuromuscul Disord, 2021, 31(10): 1004-1012. DOI: 10.1016/j.nmd.2021.08.003 .
[4]
陈婷, 蒲传强, 汪茜, 等. 中央核肌病16例临床及病理特点[J]. 中华神经科杂志, 2014, 47(6): 408-411. DOI: 10.3760/cma.j.issn.1006-7876.2014.06.012 .
[5]
Gineste C, Laporte J. Therapeutic approaches in different congenital myopathies[J]. Curr Opin Pharmacol, 2023, 68: 102328. DOI: 10.1016/j.coph.2022.102328 .
[6]
Beggs AH, Byrne BJ, De Chastonay S, et al. A multicenter, retrospective medical record review of X-linked myotubular myopathy: the recensus study[J]. Muscle Nerve, 2018, 57(4): 550-560. PMCID: PMC5900738. DOI: 10.1002/mus.26018 .
[7]
Jungbluth H, Wallgren-Pettersson C, Laporte J. Centronuclear (myotubular) myopathy[J]. Orphanet J Rare Dis, 2008, 3: 26. PMCID: PMC2572588. DOI: 10.1186/1750-1172-3-26 .
[8]
Vandersmissen I, Biancalana V, Servais L, et al. An integrated modelling methodology for estimating the prevalence of centronuclear myopathy[J]. Neuromuscul Disord, 2018, 28(9): 766-777. DOI: 10.1016/j.nmd.2018.06.012 .
[9]
Richards S, Aziz N, Bale S, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology[J]. Genet Med, 2015, 17(5): 405-424. PMCID: PMC4544753. DOI: 10.1038/gim.2015.30 .
[10]
de Gouyon BM, Zhao W, Laporte J, et al. Characterization of mutations in the myotubularin gene in twenty six patients with X-linked myotubular myopathy[J]. Hum Mol Genet, 1997, 6(9): 1499-1504. DOI: 10.1093/hmg/6.9.1499 .
[11]
Penon M, Zahed H, Berger V, et al. Using exome sequencing to decipher family history in a healthy individual: comparison of pathogenic and population MTM1 variants[J]. Mol Genet Genomic Med, 2018, 6(5): 722-727. PMCID: PMC6160706. DOI: 10.1002/mgg3.405 .
[12]
Laporte J, Hu LJ, Kretz C, et al. A gene mutated in X-linked myotubular myopathy defines a new putative tyrosine phosphatase family conserved in yeast[J]. Nat Genet, 1996, 13(2): 175-182. DOI: 10.1038/ng0696-175 .
[13]
Tanner SM, Schneider V, Thomas NS, et al. Characterization of 34 novel and six known MTM1 gene mutations in 47 unrelated X-linked myotubular myopathy patients[J]. Neuromuscul Disord, 1999, 9(1): 41-49. DOI: 10.1016/s0960-8966(98)00090-x .
[14]
Amburgey K, Tsuchiya E, de Chastonay S, et al. A natural history study of X-linked myotubular myopathy[J]. Neurology, 2017, 89(13): 1355-1364. PMCID: PMC5649758. DOI: 10.1212/WNL.0000000000004415 .
[15]
Annoussamy M, Lilien C, Gidaro T, et al. X-linked myotubular myopathy: a prospective international natural history study[J]. Neurology, 2019, 92(16): e1852-e1867. PMCID: PMC6550499. DOI: 10.1212/WNL.0000000000007319 .
[16]
耿洪志, 李伟, 焉传祝, 等. MTM1基因突变致中央核肌病一家系的临床、肌肉病理及基因突变特点[J]. 山东大学学报(医学版), 2020, 58(6): 1-7.
[17]
Biancalana V, Scheidecker S, Miguet M, et al. Affected female carriers of MTM1 mutations display a wide spectrum of clinical and pathological involvement: delineating diagnostic clues[J]. Acta Neuropathol, 2017, 134(6): 889-904. DOI: 10.1007/s00401-017-1748-0 .
[18]
Reumers SFI, Braun F, Spillane JE, et al. Spectrum of clinical features in X-linked myotubular myopathy carriers: an international questionnaire study[J]. Neurology, 2021, 97(5): e501-e512. PMCID: PMC8356379. DOI: 10.1212/WNL.0000000000012236 .
[19]
Claeys KG. Congenital myopathies: an update[J]. Dev Med Child Neurol, 2020, 62(3): 297-302. DOI: 10.1111/dmcn.14365 .
[20]
Molera C, Sarishvili T, Nascimento A, et al. Intrahepatic cholestasis is a clinically significant feature associated with natural history of X-linked myotubular myopathy (XLMTM): a case series and biopsy report[J]. J Neuromuscul Dis, 2022, 9(1): 73-82. PMCID: PMC8842755. DOI: 10.3233/JND-210712 .
[21]
Kušíková K, Šoltýsová A, Ficek A, et al. Prognostic value of genotype-phenotype correlations in X-Linked myotubular myopathy and the use of the face2gene application as an effective non-invasive diagnostic tool[J]. Genes (Basel), 2023, 14(12): 2174. PMCID: PMC10742680. DOI: 10.3390/genes14122174 .
[22]
Laporte J, Biancalana V, Tanner SM, et al. MTM1 mutations in X-linked myotubular myopathy[J]. Hum Mutat, 2000, 15(5): 393-409. DOI: 10.1002/(SICI)1098-1004(200005)15:5<393::AID-HUMU1>3.0.CO;2-R .
[23]
Abath Neto O, Silva MR, Martins Cde A, et al. A study of a cohort of X-linked myotubular myopathy at the clinical, histologic, and genetic levels[J]. Pediatr Neurol, 2016, 58: 107-112. DOI: 10.1016/j.pediatrneurol.2016.01.023 .
[24]
Gangfuss A, Schmitt D, Roos A, et al. Diagnosing X-linked myotubular myopathy: a German 20-year follow up experience[J]. J Neuromuscul Dis, 2021, 8(1): 79-90. PMCID: PMC7902950. DOI: 10.3233/JND-200539 .
[25]
张钰琦, 强荣, 王林, 等. MTM1缺失突变致X-连锁中央核性肌病的临床与遗传学分析1例[J]. 国际遗传学杂志, 2023, 46(3): 240-243. DOI: 10.3760/cma.j.cn231536-20230119-00004 .
[26]
王劲, 王丹, 李婷婷, 等. MTM1基因变异致X连锁中央核肌病患者2例的临床特征及遗传学分析[J]. 中华医学遗传学杂志, 2024, 41(7): 812-816. DOI: 10.3760/cma.j.cn511374-20230606-00345 .
[27]
Gómez-Oca R, Cowling BS, Laporte J. Common pathogenic mechanisms in centronuclear and myotubular myopathies and latest treatment advances[J]. Int J Mol Sci, 2021, 22(21): 11377. PMCID: PMC8583656. DOI: 10.3390/ijms222111377 .
[28]
Shieh PB, Kuntz NL, Dowling JJ, et al. Safety and efficacy of gene replacement therapy for X-linked myotubular myopathy (ASPIRO): a multinational, open-label, dose-escalation trial[J]. Lancet Neurol, 2023, 22(12): 1125-1139. DOI: 10.1016/S1474-4422(23)00313-7 .

脚注

所有作者均声明无利益冲突。


编委: 张辉

版权

版权所有 © 2023中国当代儿科杂志
PDF(561 KB)
HTML

Accesses

Citation

Detail

段落导航
相关文章

/